Mauro Federici
Via Del Fosso Di Fiorano 64
Rome, 00143, Italy
Rome, 00143, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
miR-218 Regulates the Excitability of VTA Dopamine Neurons and the Mesoaccumbens Pathway in Mice.
Journal: Brain sciences
Published: August 05, 2025
Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromine.
Journal: Parkinsonism & related disorders
Published: June 14, 2024
Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson's disease overexpressing human alpha synuclein.
Journal: NPJ Parkinson's disease
Published: February 05, 2024
miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: March 08, 2023
Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer's disease in Tg2576 mice.
Journal: Molecular neurodegeneration
Published: September 21, 2022
Long-Term Depression of Striatal DA Release Induced by mGluRs via Sustained Hyperactivity of Local Cholinergic Interneurons.
Journal: Frontiers in cellular neuroscience
Published: October 20, 2021
Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit.
Journal: Brain : a journal of neurology
Published: January 02, 2021
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease.
Journal: Nature communications
Published: October 16, 2019
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease.
Journal: Nature communications
Published: September 03, 2018
3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition.
Journal: Neuroscience
Published: September 22, 2017
Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease.
Journal: Nature communications
Published: June 28, 2016
Last Updated: 09/26/2026